FDA Advisory Panel Endorses Approval of Alzheimer's Drug Made by Eli LillyThe modest benefits of the treatment, donanemab, made by Eli Lilly, outweigh the risks, the panel concluded unanimously.
Source: FDA Advisory Panel Endorses Approval of Alzheimer's Drug Made by Eli Lilly (https://www.nytimes.com/2024/06/10/health/alzheimers-treatment-donanemab.html)